Ducommun Inc: Form 10-Q for the period ended Apr 2, 2022
Filed with the SEC on May 3, 2022 and accepted by EDGAR at May 3, 2022, 16:21 ET.
Management's discussion and analysis
As filed, 37,127 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Overview
Ducommun Incorporated (“Ducommun,” “the Company,” “we,” “us” or “our”) is a leading global provider of engineering and manufacturing services for high-performance products and high-cost-of failure applications used primarily in the aerospace and defense (“A&D”), industrial, medical and other industries (collectively, “Industrial”). We differentiate ourselves as a full-service solution-based provider, offering a wide range of value-added products and services in our primary businesses of electronics, structures and integrated solutions. We operate through two primary business segments: Electronic Systems and Structural Systems, each of which is a reportable segment.
COVID-19 Pandemic Impact on Our Business
The COVID-19 pandemic has had a significant impact on our overall business during the three months ended April 2, 2022. As a result of the COVID-19 pandemic, precautionary measures were instituted by governments and businesses to mitigate its spread, including the imposition of travel restrictions, quarantines, shelter in place directives, and shutting down of non-essential businesses.
The safety of our employees remains our highest priority. The well-being and safety protocols that were already in place at all of our facilities were further enhanced at the onset of the COVID-19 pandemic. We continue to follow safety protocols consistent with guidelines provided by state and local governments and the Centers for Disease Control and Prevention (“CDC”). These measures included social distancing, provision of personal protective equipment, enhanced cleaning, and flexible work arrangements wherever possible. We have also offered enhanced leave and benefits to our employees and provided frequent updates to ensure our workforce is kept apprised of evolving regulations and safety measures.
In March 2020, the U.S. enacted the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) which provides tax relief to individuals and businesses affected by the coronavirus pandemic. We have not requested or accepted any loans or payments that are available under the CARES Act, however, we have utilized the option to defer payment of the employer portion of payroll taxes (Social Security) that would otherwise be required to be made during the period beginning March 27, 2020 to December 31, 2020. One half of the deferred amount was required to be paid and was paid by December 31, 2021, with the remaining 50% to be paid by December 31, 2022. As of April 2, 2022, we have deferred $3.1 million, which is included as part of accrued liabilities and other liabilities on the condensed consolidated balance sheets.
The COVID-19 pandemic has and continues to contribute to a general slowdown in the global economy and most significantly, the commercial aerospace end-use market. While both major large aircraft manufacturers, The Boeing Company (“Boeing”) and Airbus SE, have announced increases in build rates for 2022, it is well below pre-pandemic levels. In its 2021 Annual Report on Form 10-K, Boeing indicated it expects commercial air travel to return to 2019 levels in 2023 to 2024, and a few years beyond that for the industry to return to the long-term trend growth. While the full extent and impact of the COVID-19 pandemic cannot be reasonably estimated with certainty at this time, COVID-19 has had a significant impact on our business, the businesses of our customers and suppliers, as well as our results of operations and financial condition, and may have a material adverse impact on our business, results of operations and financial condition for 2022 and beyond.
First quarter 2022 recap:
- Net revenues of $163.5 million
- Net income of $8.1 million, or $0.66 per diluted share
- Adjusted EBITDA of $20.1 million, or 12.3% of revenues
Non-GAAP Financial Measures
Adjusted earnings before interest, taxes, depreciation, amortization, stock-based compensation expense, Guaymas fire related expenses, insurance recoveries related to business interruption, and inventory purchase accounting adjustments (“Adjusted EBITDA”) were $20.1 million and $21.1 million for the three months ended April 2, 2022 and April 3, 2021, respectively.
When viewed with our financial results prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and accompanying reconciliations, we believe Adjusted EBITDA provides additional useful information that clarifies and enhances the understanding of the factors and trends affecting our past performance and future prospects. We define this measure, explain how it is calculated and provide a reconciliation of this measure to the most comparable GAAP measure in the table below. Adjusted EBITDA and the related financial ratios, as presented in this Quarterly Report on Form 10-Q (“Form 10-Q”), are supplemental measures of our performance that are not required by, or presented in accordance with, GAAP. They are not a measurement of our financial performance under GAAP and should not be considered as alternatives to net income or any other performance measures derived in accordance with GAAP, or as an alternative to net cash provided by operating activities as measures of our liquidity. The presentation of these measures should not be interpreted to mean that our future results will be unaffected by unusual or nonrecurring items.
We use Adjusted EBITDA as a non-GAAP operating performance measure internally as a complementary financial measure to evaluate the performance and trends of our businesses. We present Adjusted EBITDA and the related financial ratios, as applicable, because we believe that measures such as these provide useful information with respect to our ability to meet our operating commitments.
Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations include:
- It does not reflect our cash expenditures, future requirements for capital expenditures or contractual commitments;
- It does not reflect changes in, or cash requirements for, our working capital needs;
- It does not reflect the significant interest expense or the cash requirements necessary to service interest or principal payments on our debt;
- Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;
- It is not adjusted for all non-cash income or expense items that are reflected in our statements of cash flows;
- It does not reflect the impact on earnings of charges resulting from matters unrelated to our ongoing operations; and
- Other companies in our industry may calculate Adjusted EBITDA differently from us, limiting its usefulness as a comparative measure.
As a result of these limitations, Adjusted EBITDA and the related financial ratios should not be considered as measures of discretionary cash available to us to invest in the growth of our business or as a measure of cash that will be available to us to meet our obligations. You should compensate for these limitations by relying primarily on our GAAP results and using Adjusted EBITDA only as supplemental information. See our condensed consolidated financial statements contained in this Form 10-Q.
Even with the limitations above, we believe that Adjusted EBITDA is useful to an investor in evaluating our results of operations as this measure:
- Is widely used by investors to measure a company’s operating performance without regard to items excluded from the calculation of such terms, which can vary substantially from company to company depending upon accounting methods and book value of assets, capital structure and the method by which assets were acquired, among other factors;
- Helps investors to evaluate and compare the results of our operations from period to period by removing the effect of our capital structure from our operating performance; and
- Is used by our management team for various other purposes in presentations to our Board of Directors as a basis for strategic planning and forecasting.
The following financial items have been added back to or subtracted from our net income when calculating Adjusted EBITDA:
- Interest expense may be useful to investors for determining current cash flow;
- Income tax expense may be useful to investors because it represents the taxes which may be payable for the period and the change in deferred taxes during the period, and may reduce cash flow available for use in our business;
- Depreciation may be useful to investors because it generally represents the wear and tear on our property and equipment used in our operations;
- Amortization expense may be useful to investors because it represents the estimated attrition of our acquired customer base and the diminishing value of product rights;
- Stock-based compensation may be useful to our investors for determining current cash flow;
- Guaymas fire related expenses may be useful to our investors in evaluating our core operating performance;
- Insurance recoveries related to business interruption may be useful to our investors in evaluating our core operating performance; and
- Purchase accounting inventory step-ups may be useful to our investors as they do not necessarily reflect the current or on-going cash charges related to our core operating performance.
Reconciliations of net income to Adjusted EBITDA and the presentation of Adjusted EBITDA as a percentage of net revenues were as follows:
(Dollars in thousands)
| Three Months Ended April 2, 2022 | April 3, 2021 | |
|---|---|---|
| Net income | $8,099 | $6,695 |
| Interest expense | 2,402 | 2,806 |
| Income tax expense | 1,622 | 1,109 |
| Depreciation | 3,587 | 3,423 |
| Amortization | 4,181 | 3,499 |
| Stock-based compensation expense | 1,590 | 3,133 |
| Guaymas fire related expenses | 957 | 475 |
| Insurance recoveries related to business interruption | (3,000) | — |
| Inventory purchase accounting adjustments | 637 | — |
| Adjusted EBITDA | $20,075 | $21,140 |
| % of net revenues | 12.3% | 13.5% |
23
Results of Operations
First Quarter of 2022 Compared to First Quarter of 2021
The following table sets forth net revenues, selected financial data, the effective tax rate and diluted earnings per share:
| (Dollars in thousands, except per share data) Three Months Ended April 2, 2022 | % of Net Revenues | April 3, 2021 | % of Net Revenues | |
|---|---|---|---|---|
| Net Revenues | $163,481 | 100.0% | $157,151 | 100.0% |
| Cost of Sales | 131,006 | 80.1% | 124,051 | 78.9% |
| Gross Profit | 32,475 | 19.9% | 33,100 | 21.1% |
| Selling, General and Administrative Expenses | 23,352 | 14.3% | 22,490 | 14.3% |
| Operating Income | 9,123 | 5.6% | 10,610 | 6.8% |
| Interest Expense | (2,402) | (1.5)% | (2,806) | (1.8)% |
| Other Income | 3,000 | 1.8% | — | —% |
| Income Before Taxes | 9,721 | 5.9% | 7,804 | 5.0% |
| Income Tax Expense | 1,622 | nm | 1,109 | nm |
| Net Income | $8,099 | 5.0% | $6,695 | 4.3% |
| Effective Tax Rate | 16.7% | nm | 14.2% | nm |
| Diluted Earnings Per Share | $0.66 | nm | $0.55 | nm |
nm = not meaningful
Net Revenues by End-Use Market and Operating Segment
Net revenues by end-use market and operating segment during the fiscal three months ended April 2, 2022 and April 3, 2021, respectively, were as follows:
(Dollars in thousands)
| Consolidated Ducommun | Three Months Ended Change | April 2, 2022 | April 3, 2021 | % of Net Revenues April 2, 2022 | April 3, 2021 |
|---|---|---|---|---|---|
| Military and space | $(14,793) | $99,334 | $114,127 | 60.8% | 72.6% |
| Commercial aerospace | 18,698 | 54,075 | 35,377 | 33.1% | 22.5% |
| Industrial | 2,425 | 10,072 | 7,647 | 6.1% | 4.9% |
| Total | $6,330 | $163,481 | $157,151 | 100.0% | 100.0% |
| Electronic Systems | |||||
| Military and space | $(9,913) | $71,820 | $81,733 | 73.7% | 82.5% |
| Commercial aerospace | 5,850 | 15,574 | 9,724 | 16.0% | 9.8% |
| Industrial | 2,425 | 10,072 | 7,647 | 10.3% | 7.7% |
| Total | $(1,638) | $97,466 | $99,104 | 100.0% | 100.0% |
| Structural Systems | |||||
| Military and space | $(4,880) | $27,514 | $32,394 | 41.7% | 55.8% |
| Commercial aerospace | 12,848 | 38,501 | 25,653 | 58.3% | 44.2% |
| Total | $7,968 | $66,015 | $58,047 | 100.0% | 100.0% |
Net revenues for the three months ended April 2, 2022 were $163.5 million, compared to $157.2 million for the three months ended April 3, 2021. The year-over-year increase was primarily due to the following:
- $18.7 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms, other commercial aerospace platforms, and regional and business aircraft platforms; partially offset by
- $14.8 million lower revenues in our military and space end-use markets due to lower build rates on other military and space platforms, various missile platforms, and military rotary-wing aircraft platforms.
Net Revenues by Major Customers
A significant portion of our net revenues are from our top ten customers as follows:
| Three Months Ended April 2, 2022 | April 3, 2021 | |
|---|---|---|
| Boeing Company | 7.1% | 7.4% |
| General Dynamics Corporation | 5.2% | 2.6% |
| Lockheed Martin Corporation | 3.7% | 5.3% |
| Northrop Grumman Corporation | 6.7% | 6.1% |
| Raytheon Technologies Corporation | 20.5% | 22.7% |
| Total top ten customers (1) | 59.5% | 58.5% |
(1) Includes The Boeing Company (“Boeing”), General Dynamics Corporation (“GD”), Lockheed Martin Corporation (“Lockheed”), Northrop Grumman Corporation (“Northrop”), and Raytheon Technologies Corporation (“Raytheon”) for the three months ended April 2, 2022 and April 3, 2021.
Boeing, GD, Lockheed, Northrop, and Raytheon represented the following percentages of total accounts receivable:
| April 2, 2022 | December 31, 2021 | |
|---|---|---|
| Boeing | 4.9% | 3.5% |
| GD | 6.3% | 4.0% |
| Lockheed | 2.1% | 0.4% |
| Northrop | 8.1% | 10.9% |
| Raytheon | 16.6% | 17.8% |
The net revenues and accounts receivable from Boeing, GD, Lockheed, Northrop, and Raytheon, are diversified over a number of commercial, military and space programs and were generated by both operating segments.
Gross Profit
Gross profit consists of net revenues less cost of sales. Cost of sales includes the cost of production of finished products and other expenses related to inventory management, manufacturing quality, and order fulfillment. Gross profit as a percentage of net revenues decreased year-over-year with the three months ended April 2, 2022 of 19.9%, compared to the three months ended April 3, 2021 of 21.1% primarily due to unfavorable product mix, partially offset by lower compensation and benefits costs.
Selling, General and Administrative (“SG&A”) Expenses
SG&A expenses increased $0.9 million year-over-year in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 primarily due to one-time severance charges of $1.2 million.
Interest Expense
Interest expense decreased $0.4 million year-over-year in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 primarily due to a lower outstanding debt balance, partially offset by higher interest rates.
Income Tax Expense
We recorded income tax expense of $1.6 million for the three months ended April 2, 2022, compared to $1.1 million for the three months ended April 3, 2021. The increase in income tax expense for the first quarter of 2022 compared to the first quarter of 2021 was primarily due to higher pre-tax income for the first quarter of 2022 compared to the first quarter of 2021 and lower discrete tax benefits recognized in the first quarter of 2022 for net tax windfalls related to stock-based compensation. The increase in income tax expense was partially offset by higher income tax benefits recognized in the first quarter of 2022 mainly related to the U.S. Federal research and development tax credit.
Our total amount of unrecognized tax benefits was $4.5 million and $4.4 million as of April 2, 2022 and December 31, 2021, respectively. If recognized, $2.7 million would affect the effective tax rate. We record interest and penalty charges, if any, related to uncertain tax positions as a component of tax expense and unrecognized tax benefits. The amounts accrued for interest and penalty charges as of April 2, 2022 and December 31, 2021 were not significant. As a result of statute of limitations set to expire in the fourth quarter of 2022, we expect decreases to our unrecognized tax benefits of approximately $0.7 million in the next twelve months.
We file U.S. Federal and state income tax returns. We are subject to examination by the Internal Revenue Service (“IRS”) for tax years after 2017 and by state taxing authorities for tax years after 2016. While we are no longer subject to examination prior to those periods, carryforwards generated prior to those periods may still be adjusted upon examination by the IRS or state taxing authorities if they either have been or will be used in a subsequent period. We believe we have adequately accrued for tax deficiencies or reductions in tax benefits, if any, that could result from the examination and all open audit years.
The Tax Cuts and Jobs Act of 2017 (“TCJA”), which was signed into U.S. law in December 2017, eliminated the option to immediately deduct research and development expenditures in the year incurred under Section 174 effective January 1, 2022. The amended provision under Section 174 requires us to capitalize and amortize these expenditures over five years (for U.S.-based research). Although there is proposed legislation to temporarily reinstate the current deduction of the expenditures after 2021 through 2025, we must consider the changes under the TCJA. As of April 2, 2022, we recorded an increase to current income taxes payable by approximately $2.6 million and a decrease to net deferred tax liabilities by a similar amount. We are monitoring legislation for any further changes to Section 174 and the impact to the financial statements in 2022.
Net Income and Earnings per Share
Net income and earnings per share for the three months ended April 2, 2022 were $8.1 million, or $0.66 per diluted share, compared to $6.7 million, or $0.55 per diluted share, for the three months ended April 3, 2021. The increase in net income for the three months ended
April 2, 2022 compared to the three months ended April 3, 2021 was primarily due to higher other income of $3.0 million, partially offset by higher selling, general and administrative expenses of $0.9 million.
Business Segment Performance
We report our financial performance based upon the two reportable operating segments: Electronic Systems and Structural Systems. The results of operations differ between our reportable operating segments due to differences in competitors, customers, extent of proprietary deliverables and performance. The following table summarizes our business segment performance for the three months ended April 2, 2022 and April 3, 2021:
(Dollars in thousands)
| Net Revenues | Three Months Ended % Change | April 2, 2022 | April 3, 2021 | % of Net Revenues April 2, 2022 | April 3, 2021 |
|---|---|---|---|---|---|
| Electronic Systems | (1.7)% | $97,466 | $99,104 | 59.6% | 63.1% |
| Structural Systems | 13.7% | 66,015 | 58,047 | 40.4% | 36.9% |
| Total Net Revenues | 4.0% | $163,481 | $157,151 | 100.0% | 100.0% |
| Segment Operating Income | |||||
| Electronic Systems | $9,411 | $12,491 | 9.7% | 12.6% | |
| Structural Systems | 4,887 | 5,128 | 7.4% | 8.8% | |
| 14,298 | 17,619 | ||||
| Corporate General and Administrative Expenses (1) | (5,175) | (7,009) | (3.2)% | (4.5)% | |
| Total Operating Income | $9,123 | $10,610 | 5.6% | 6.8% | |
| Adjusted EBITDA | |||||
| Electronic Systems | |||||
| Operating Income | $9,411 | $12,491 | |||
| Depreciation and Amortization | 3,506 | 3,423 | |||
| 12,917 | 15,914 | 13.3% | 16.1% | ||
| Structural Systems | |||||
| Operating Income | 4,887 | 5,128 | |||
| Depreciation and Amortization | 4,203 | 3,440 | |||
| Guaymas fire related expenses | 957 | 475 | |||
| Inventory Purchase Accounting Adjustments | 637 | — | |||
| 10,684 | 9,043 | 16.2% | 15.6% | ||
| Corporate General and Administrative Expenses (1) | |||||
| Operating Loss | (5,175) | (7,009) | |||
| Depreciation and Amortization | 59 | 59 | |||
| Stock-Based Compensation Expense | 1,590 | 3,133 | |||
| (3,526) | (3,817) | ||||
| Adjusted EBITDA | $20,075 | $21,140 | 12.3% | 13.5% | |
| Capital Expenditures | |||||
| Electronic Systems | $1,696 | $624 | |||
| Structural Systems | 3,372 | 1,989 | |||
| Corporate Administration | — | — | |||
| Total Capital Expenditures | $5,068 | $2,613 |
(1) Includes costs not allocated to either the Electronic Systems or Structural Systems operating segments.
Electronic Systems
Electronic Systems net revenues in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 decreased $1.6 million primarily due to the following:
- $9.9 million lower revenues in our military and space end-use markets due to lower build rates on other military and space platforms and various missile platforms; partially offset by
- $5.9 million higher revenues in our commercial aerospace end-use markets due to higher build rates on other commercial aerospace platforms.
Electronic Systems segment operating income in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 decreased $3.1 million primarily due to unfavorable manufacturing volume and unfavorable product mix.
Structural Systems
Structural Systems net revenues in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 increased
$8.0 million primarily due to the following:
- $12.8 million higher revenues in our commercial aerospace end-use markets due to higher build rates on large aircraft platforms and regional and business aircraft platforms; partially offset by
- $4.9 million lower revenues in our military and space end-use markets due to lower build rates on military rotary-wing aircraft platforms.
The Structural Systems segment operating income in the three months ended April 2, 2022 compared to the three months ended April 3, 2021 decreased $0.2 million primarily due to unfavorable product mix, partially offset by favorable manufacturing volume and lower compensation and benefits costs.
In June 2020, a fire severely damaged our performance center in Guaymas, Mexico. We have insurance coverage and up to a capped amount, expect these items will be covered, less our deductible. The full financial impact cannot be estimated at this time as we are currently working with our insurance carriers to determine the cause of the fire. The loss of production from the Guaymas performance center is being absorbed by our other existing performance centers, however, we are in the process of re-establishing manufacturing capabilities in a different leased facility in Guaymas. A neighboring, non-related manufacturing facility, also suffered fire damage during the same time as the fire that severely damaged our Guaymas performance center. The cause of the fire is still undetermined and as such, there is no amount of loss that is probable and reasonably estimable at this time. If we are ultimately deemed to be responsible or partly responsible, it is possible we could incur a loss in excess of our insurance coverage limits, which could be material to our cash flow, liquidity, or financial results. See Note 7 and Note 9 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q.
Corporate General and Administrative (“CG&A”) Expenses
CG&A expenses decreased $1.8 million for the three months ended April 2, 2022 compared to the three months ended April 3, 2021 primarily due to lower compensation and benefits costs of $1.8 million.
Backlog
We define backlog as customer placed purchase orders (“POs”) and long-term agreements (“LTAs”) with firm fixed price and expected delivery dates of 24 months or less. The majority of the LTAs do not meet the definition of a contract under ASC 606 and thus, the backlog amount disclosed below is greater than the remaining performance obligations amount disclosed in Note 1 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q. Backlog is subject to delivery delays or program cancellations, which are beyond our control. Backlog is affected by timing differences in the placement of customer orders and tends to be concentrated in several programs to a greater extent than our net revenues. Backlog in industrial markets tends to be of a shorter duration and is generally fulfilled within a three month period. As a result of these factors, trends in our overall level of backlog may not be indicative of trends in our future net revenues.
The increase in backlog was primarily in the commercial aerospace end-use market, partially offset by a decrease in the military and space end-use market. $664.0 million of total backlog is expected to be delivered over the next 12 months. The following table summarizes our backlog as of April 2, 2022 and December 31, 2021:
(Dollars in thousands)
| Consolidated Ducommun | Change | April 2, 2022 | December 31, 2021 |
|---|---|---|---|
| Military and space | $(11,113) | $509,165 | $520,278 |
| Commercial aerospace | 43,654 | 376,761 | 333,107 |
| Industrial | 5,020 | 56,822 | 51,802 |
| Total | $37,561 | $942,748 | $905,187 |
| Electronic Systems | |||
| Military and space | $(11,366) | $388,636 | $400,002 |
| Commercial aerospace | 21,918 | 78,728 | 56,810 |
| Industrial | 5,020 | 56,822 | 51,802 |
| Total | $15,572 | $524,186 | $508,614 |
| Structural Systems | |||
| Military and space | $253 | $120,529 | $120,276 |
| Commercial aerospace | 21,736 | 298,033 | 276,297 |
| Total | $21,989 | $418,562 | $396,573 |
30
Liquidity and Capital Resources
Available Liquidity
Total debt, the weighted-average interest rate, cash and cash equivalents and available credit facilities were as follows:
(Dollars in millions)
| April 2, 2022 | December 31, 2021 | |
|---|---|---|
| Total debt, including long-term portion | $256.0 | $287.7 |
| Weighted-average interest rate on debt | 3.37% | 3.27% |
| Term Loans interest rate | 3.28% | 3.22% |
| Cash and cash equivalents | $19.3 | $76.3 |
| Unused Revolving Credit Facility | $99.8 | $99.8 |
In December 2019, we completed the refinancing of a portion of our existing debt by entering into a new revolving credit facility (“2019 Revolving Credit Facility”) to replace the then existing revolving credit facility that was entered into in November 2018 (“2018 Revolving Credit Facility”) and entered into a new term loan (“2019 Term Loan”). The 2019 Revolving Credit Facility is a $100.0 million senior secured revolving credit facility that will mature on December 20, 2024, replacing the $100.0 million 2018 Revolving Credit Facility that would have matured on November 21, 2023. The 2019 Term Loan is a $140.0 million senior secured term loan that will mature on December 20, 2024. We also have an existing $240.0 million senior secured term loan that was entered into in November 2018 that will mature on November 21, 2025 (“2018 Term Loan”). The original amounts available under the 2019 Revolving Credit Facility, 2019 Term Loan, and 2018 Term Loan (collectively, the “Credit Facilities”) in aggregate, totaled $480.0 million. We are required to make installment payments of 1.25% of the original outstanding principal balance of the 2019 Term Loan amount on a quarterly basis, on the last day of the calendar quarter. We made the mandatory quarterly principal prepayment under the 2019 Term Loan during the three months ended April 2, 2022 of $1.8 million. In addition, if we meet the annual excess cash flow threshold, we are required to make an annual additional principal payment on the 2018 Term Loan based on the consolidated adjusted leverage ratio. We did not exceed the annual excess cash flow threshold for 2021 and thus, no annual excess cash flow payment was required to be paid during the first quarter of 2022. Further, the undrawn portion of the commitment of the 2019 Revolving Credit Facility is subject to a commitment fee ranging from 0.175% to 0.275%, based upon the consolidated total net adjusted leverage ratio. As of April 2, 2022, we were in compliance with all covenants required under the Credit Facilities. See Note 6 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.
In November 2018, we completed credit facilities to replace the then existing credit facilities. The November 2018 credit facilities consisted of the 2018 Term Loan and the 2018 Revolving Credit Facility (collectively, the “2018 Credit Facilities”). We were required to make installment payments of 0.25% of the outstanding principal balance of the 2018 Term Loan amount on a quarterly basis, however, in conjunction with the 2019 refinancing where we paid down $56.0 million on the 2018 Term Loan, it paid all the required quarterly installment payments on the 2018 Term Loan until maturity.
However, since we were paying down on the term loans during the three months ended April 2, 2022, we were required to pay down on the 2019 Term Loan and 2018 Term Loan on a pro-rata basis and thus, we paid down $13.0 million and $17.0 million on the 2019 Term Loan and 2018 Term Loan, respectively, for an aggregate total pay down of $30.0 million.
Subsequent to our quarter ended April 2, 2022, in April 2022, management approved and commenced a restructuring plan mainly to reduce headcount, consolidate facilities, write-down inventory, and impair long-lived assets to better position us for stronger performance. We currently anticipate this initiative will result in $10.0 million to $14.0 million in total pre-tax restructuring charges over the next 12 months. Of these charges, we estimate $4.0 million to be cash payments for employee separation and other facility consolidation related expenses, and $6.0 million to $10.0 million to be non-cash charges for the write-down of inventory and impairment of long-lived assets. On an annualized basis, we anticipate these restructuring actions will result in total cost savings of $3.0 million to $4.0 million. See Note 1 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.
In November 2021, we entered into derivative contracts, U.S. dollar-one month LIBOR forward interest rate swaps designated as cash flow hedges, all with an effective date of January 1, 2024, for an aggregate total notional amount of $150.0 million, weighted average fixed rate of 1.8%, and all terminating on January 1, 2031 (“Forward Interest Rate Swaps”). The Forward Interest Rate Swaps mature on a monthly basis, with fixed amount payer payment dates on the first day of each calendar month, commencing on February 1, 2024 through January 1, 2031. See Note 1 and Note 6 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.
In December 2021, we acquired MagSeal for a purchase price of $69.5 million, net of cash acquired, all payable in cash. Upon the closing of the transaction, we paid a gross total aggregate of $71.3 million in cash, a portion of which was by drawing down on the 2019 Revolving Credit Facility. This draw down on the 2019 Revolving Credit Facility was paid off by December 31, 2021. See Note 2 to our condensed consolidated financial statements included in Part I, Item 1 of this Form 10-Q for further information.
In December 2021, we entered into a sale-leaseback transaction for the building and related land for our Gardena performance center located in Carson, California (“Sale-Leaseback Agreement”). The building and related land was sold for $141.3 million and we recognized a gain of $132.5 million. As part of the Sale-Leaseback Agreement, we entered into an initial five year lease for the usage of the just sold building and related land. The future minimum base monthly lease payments during the initial five year period in aggregate total $19.6 million.
We expect to spend a total of $16.0 million to $18.0 million for capital expenditures in 2022 (excluding capital expenditures we will spend to restore the manufacturing capabilities related to our Guaymas performance center that was severely damaged by fire in June 2020), financed by cash generated from operations, principally to support new contract awards in Electronic Systems and Structural Systems. As part of our strategic plan to become a supplier of a wider range of higher-level assemblies and win new contract awards, additional up-front investment in tooling will be required for newer programs which have higher engineering content and higher levels of complexity in assemblies. However, some portion of the expected capital expenditures in 2022 could be delayed as a result of the ongoing COVID-19 pandemic.
We believe the ongoing aerospace and defense subcontractor consolidation makes acquisitions an increasingly important component of our future growth. We will continue to make prudent acquisitions and capital expenditures for manufacturing equipment and facilities to support long-term contracts for commercial and military aircraft and defense programs.
We monitor our asset base, including the market dynamics of the properties we own, and we may sell such properties and/or enter into sale-leaseback transactions. Such transactions would provide cash for various capital deployment options.
We continue to depend on operating cash flow and the availability of our Credit Facilities to provide short-term liquidity. Cash generated from operations and bank borrowing capacity is expected to provide sufficient liquidity to meet our obligations during the next twelve months from the date of issuance of these financial statements.
Cash Flow Summary
Net cash used in operating activities for the three months ended April 2, 2022 was $18.9 million, compared to $23.4 million for the three months ended April 3, 2021. The lower net cash used in operating activities during the first three months of 2022 was mainly due to higher accounts payable and higher net income, partially offset by lower accrued and other liabilities, higher contract assets, higher accounts receivable, and higher inventories.
Net cash used in investing activities was $4.8 million for the three months ended April 2, 2022, compared to $4.5 million in the three months ended April 3, 2021. The higher net cash used during the first three months of 2022 compared to the prior year period was mainly due to higher purchases of property and equipment.
Net cash used in financing activities was $33.4 million for the three months ended April 2, 2022, compared to $11.6 million for the three months ended April 3, 2021. The higher net cash used in financing activities during the first three months of 2022 was mainly due to the $30.0 million pay down on term loans during the three months ended April 2, 2022.
Off-Balance Sheet Arrangements
Our off-balance sheet arrangements consist of operating and finance leases not recorded as a result of the practical expedients utilized, right of offset of industrial revenue bonds and associated failed sales-leasebacks on property and equipment, and indemnities, none of which we believe may have a material current or future effect on our financial condition, liquidity, capital resources, or results of operations.
Critical Accounting Policies
The preparation of our condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires estimation and judgment that affect the reported amounts of net revenues, expenses, assets and liabilities. For a description of our critical accounting policies, please refer to “Critical Accounting Policies” in Part II, Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our 2021 Annual Report on Form 10-K. There have been no material changes in any of our critical accounting policies during the three months ended April 2, 2022.
Recent Accounting Pronouncements
See “Part I, Item 1. Ducommun Incorporated and Subsidiaries—Notes to Condensed Consolidated Financial Statements—Note 1. Summary of Significant Accounting Policies—Recent Accounting Pronouncements” for further information.
Market risk
As filed, 1,868 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Our main market risk exposure relates to changes in U.S. and U.K. interest rates on our outstanding long-term debt. At April 2, 2022, we had total borrowings of $256.0 million under our Credit Facilities.
The 2019 Term Loan bears interest, at our option, at a rate equal to either (i) the Eurodollar Rate (defined as the London Interbank Offered Rate [“LIBOR”]) plus an applicable margin ranging from 1.50% to 2.50% per year or (ii) the Base Rate (defined as the highest of [a] Federal Funds Rate plus 0.50%, [b] Bank of America’s prime rate, and [c] the Eurodollar Rate plus 1.00%) plus an applicable margin ranging from 0.50% to 1.50% per year, in each case based upon the consolidated total net adjusted leverage ratio.
The 2019 Revolving Credit Facility bears interest, at our option, at a rate equal to either (i) the Eurodollar Rate (defined as LIBOR) plus an applicable margin ranging from 1.50% to 2.50% per year or (ii) the Base Rate (defined as the highest of [a] Federal Funds Rate plus 0.50%, [b] Bank of America’s prime rate, and [c] the Eurodollar Rate plus 1.00%) plus an applicable margin ranging from 0.50% to 1.50% per year, in each case based upon the consolidated total net adjusted leverage ratio.
The 2018 Term Loan bears interest, at our option, at a rate equal to either (i) the Eurodollar Rate (defined as LIBOR plus an applicable margin ranging from 3.75% to 4.00% per year or (ii) the Base Rate (defined as the highest of [a] Federal Funds Rate plus 0.50%, [b] Bank of America’s prime rate, and [c] the Eurodollar Rate plus 1.00%) plus an applicable margin ranging from 3.75% to 4.00% per year, in each case based upon the consolidated total net adjusted leverage ratio.
A hypothetical 10% increase or decrease in the interest rate would have an immaterial impact on our financial condition and results of operations.
Controls and procedures
As filed, 711 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Disclosure Controls and Procedures
The Company’s chief executive officer (“CEO”) and chief financial officer (“CFO”) have conducted an evaluation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934), and concluded that such disclosure controls and procedures were effective as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the three months ended April 2, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 307 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
See Part I, Item 1A of our Annual Report on Form 10-K (“Form 10-K”) for the year ended December 31, 2021 for a discussion of our risk factors. There have been no material changes during the three months ended April 2, 2022 to the risk factors disclosed in our Form 10-K for the year ended December 31, 2021.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-04-02. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-01-01 to 2022-04-02 | $163.5m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2022-01-01 to 2022-04-02 | $131.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-01-01 to 2022-04-02 | $32.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2022-01-01 to 2022-04-02 | $23.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-01-01 to 2022-04-02 | $9.1m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2022-01-01 to 2022-04-02 | $1.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-01-01 to 2022-04-02 | $8.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2022-01-01 to 2022-04-02 | $0.66 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2022-01-01 to 2022-04-02 | $0.68 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2022-01-01 to 2022-04-02 | 12,328,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2022-01-01 to 2022-04-02 | −$18.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2022-01-01 to 2022-04-02 | $4.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2022-04-02 | $19.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2022-04-02 | $465.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2022-04-02 | $959.3m | us-gaap:Assets |
| Current liabilities | At period end2022-04-02 | $158.6m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2022-04-02 | $471.6m | us-gaap:Liabilities |
| Long-term debt | At period end2022-04-02 | $249.0m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2022-04-02 | $7.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2022-04-02 | $487.7m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-22-011997. Last ingested by Listed: Nov 10, 2026, 01:39 ET. Listed shows no prices and gives no investment advice.